BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27461623)

  • 1. A non-invasive study to estimate and compare salivary sialic acid level as tumor marker in patients with pre-cancer and oral cancer.
    Jacob TV; Ramesh M; Murali S; Ramesh K; Sanjay PR; Abraham P
    J Cancer Res Ther; 2016; 12(2):634-9. PubMed ID: 27461623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
    Guruaribam VD; Sarumathi T
    J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of salivary sialic acid, total protein, and total sugar in oral cancer: a preliminary report.
    Sanjay PR; Hallikeri K; Shivashankara AR
    Indian J Dent Res; 2008; 19(4):288-91. PubMed ID: 19075429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.
    Azeem MS; Yesupatham ST; Mohiyuddin SMA; Sumanth V; Ravishankar S
    J Cancer Res Ther; 2020; 16(3):605-611. PubMed ID: 32719275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
    Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
    Achalli S; Madi M; Babu SG; Shetty SR; Kumari S; Bhat S
    Indian J Dent Res; 2017; 28(4):395-399. PubMed ID: 28836530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
    Awasthi N
    Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary microRNAs in oral cancer.
    Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
    Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H; Kumar CA
    Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
    Metgud R; Bajaj S
    Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
    Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
    J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
    Wang Q; Gao P; Wang X; Duan Y
    Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
    Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
    Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
    Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
    Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
    Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
    Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy.
    Metgud R; Patel S
    Biotech Histochem; 2014 Jan; 89(1):8-13. PubMed ID: 23738795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
    Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
    Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
    Nandakumar A; Nataraj P; James A; Krishnan R; K M M
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.